Chiron Swings Q3 Profit, Despite Flu Vaccine Issues
122658
(10/22/04)âChiron Corp. Wednesday reported net income of US$23.5 million, or $0.12 for the third quarter, compared with a loss of $19 million, or $0.
139031
Boston Scientific Corp. (BSX.N: Quote, Profile, Research) on Tuesday said its quarterly net earnings rose as sales of its new cardiovascular device bolstered results despite a costly recall.
222125
Shares of Chiron Corp., the world&#39;s second-biggest seller of influenza vaccines, fell as much as 9.5 percent after saying it would delay shipments of its Fluvirin flu shots until October because of a possible product flaw.
683806
The biotech company reported net income of $833 million, or 71 cents per share, for the latest quarter.
72531
The Chiron Corporation, a major manufacturer of influenza vaccine, said that it had detected a contamination problem in its new supply and was delaying release of nearly 50 million doses.
139829
T. Rowe Price announced solid third-quarter results.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
331259
The company said quarterly profit rose to $494 million despite a slowing U.S. economy, but it lowered its full-year earnings outlook.
716
Johnson & Johnson JNJ.N on Tuesday  said its third-quarter profit rose almost 14 percent on higher  sales of prescription drugs, but U.S. sales of medical devices  slipped on competition from a rival heart device.
444697
SAN FRANCISCO - The nation's supply of vaccine for the impending flu season took a big hit Thursday when Chiron Corp. announced it had found tainted doses in its factory...
482214
Chiron, the biotechnology company that left the US short of half its normal supply of flu vaccine this winter after contamination fears at its Speke factory in Liverpool, has
388807
The company Friday said it expected to post a profit in the third quarter, thanks to Improved pricing and product mix and higher unit volume, reversing a year-ago loss.
623829
Third-quarter profit rose 15 percent to $1.28 billion as  premium and fee growth in its Medicaid business helped offset lower enrollment in employer-sponsored programs.
152883
U.K. regulators have extended the suspension of Chiron Corp.'s influenza vaccine production in Liverpool, England for another three months from Jan. 4, the company said on Tuesday.
11643
DuPont Co.  posted a third-quarter profit, reversing a year-ago loss, as higher chemical prices offset surging energy costs, the second-largest U.S. chemicals maker said on Tuesday.
713279
Swiss pharmaceuticals giant Novartis AG on Thursday reported a 21 percent rise in third-quarter net profit to $1.55 billion.
671401
Health insurer UnitedHealth Group Inc. said Tuesday its fourth-quarter earnings climbed 3 percent, as growth in prescription services and Medicaid plans offset a smaller profit in its core health coverage division.